Algert Global’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-14,873
Closed -$1.02M 1478
2024
Q2
$1.02M Buy
14,873
+5,003
+51% +$339K 0.03% 677
2024
Q1
$716K Buy
+9,870
New +$660K 0.03% 698
2022
Q3
Sell
-22,023
Closed -$1.29M 1294
2022
Q2
$1.29M Buy
22,023
+4,843
+28% +$267K 0.1% 366
2022
Q1
$910K Buy
+17,180
New +$992K 0.06% 569
2020
Q2
Sell
-9,280
Closed -$340K 482
2020
Q1
$340K Sell
9,280
-19,649
-68% -$763K 0.14% 224
2019
Q4
$1.17M Buy
28,929
+14,915
+106% +$556K 0.35% 105
2019
Q3
$486K Sell
14,014
-14,198
-50% -$468K 0.18% 156
2019
Q2
$894K Buy
+28,212
New +$838K 0.33% 107
2016
Q2
Sell
-5,937
Closed -$317K 393
2016
Q1
$317K Buy
+5,937
New +$292K 0.12% 279
2014
Q1
Sell
-19,770
Closed -$708K 361
2013
Q4
$708K Sell
19,770
-9,300
-32% -$309K 0.19% 181
2013
Q3
$876K Hold
29,070
0.25% 142
2013
Q2
$847K Buy
+29,070
New +$820K 0.26% 142

Other funds holding PBH

Algert Global's PBH Position: Q3 2024 in Review

Algert Global sold out of Prestige Consumer Healthcare (PBH) in Q3 2024, closing a stake of 14,873 shares — an estimated $1.02M sold.

Algert Global first reported a position in PBH in Q2 2013 and held it in 12 quarters. The position peaked at $1.29M in Q2 2022. 328 funds tracked by Wall St. Rank hold PBH as of Q3 2024.

  • Algert Global reported no remaining Prestige Consumer Healthcare position as of Q3 2024 after selling out during the quarter.
  • Algert Global sold 14,873 Prestige Consumer Healthcare shares in Q3 2024, an estimated $1.02M.
  • Algert Global first reported a position in Prestige Consumer Healthcare in Q2 2013 and held it in 12 quarters.
  • Algert Global's Prestige Consumer Healthcare position peaked at $1.29M in Q2 2022.
  • 328 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q3 2024.

Based on Algert Global's 13F filing for Q3 2024, filed 12 Nov 2024.